Israeli AI Startup Converge Bio Raises $25M to Transform Drug Discovery
Israeli AI startup Converge Bio secures $25 million Series A funding, bringing total to $30M for its AI drug discovery platform.




















Israeli AI startup Converge Bio secures $25 million Series A funding, bringing total to $30M for its AI drug discovery platform.